OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK".
| trading_symbol | registrant_name | time | price | change | percentage_change | 
|---|---|---|---|---|---|
| OPK | OPKO HEALTH, INC. | 2025-10-30 18:52:35 | 1.45 | -0.01 | -0.68 | 
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPK | 0000944809 | OPKO HEALTH, INC. | US68375N1037 | 529900A4S2D4OGOJLL02 | 752402409 | Nasdaq | 2834 | Pharmaceutical Preparations | 1231 | DE | 4400 BISCAYNE BLVD. | MIAMI | FL | 33137 | UNITED STATES | US | 305-575-4181 | 4400 BISCAYNE BLVD., MIAMI, FL, 33137 | 4400 BISCAYNE BLVD., MIAMI, FL, 33137 | EXEGENICS INC | — | 1991 | — | 6,096 | https://opko.com | 414,913,527 | 798,901,457 | 767,701,280 | OPKO Health, Inc. is a medical test and medication company focused on diagnostics and pharmaceuticals. The company is a publicly traded company on NASDAQ and TASE under the symbol "OPK". | 2025-10-30 14:28:13 | 
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding | 
|---|---|---|---|---|---|---|
| 2024 | 414,913,527 | -489,569,904 | -54.127 | 671,550,270 | -25,441,397 | -3.6502 | 
| 2023 | 904,483,431 | -156,779,292 | -14.7729 | 696,991,667 | -75,659,145 | -9.7922 | 
| 2022 | 1,061,262,723 | -545,918,630 | -33.9675 | 772,650,812 | 91,125,631 | 13.3708 | 
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation | 
|---|---|---|---|---|---|---|---|---|
| Steven D. Rubin | Executive Vice President | 2020 | 810,000 | 0 | — | — | 11,200 | 1,262,200 | 
| Adam Logal | Chief Financial Officer, Senior Vice President | 2020 | 600,000 | 500,000 | — | — | 11,200 | 1,552,200 | 
| Phillip Frost | Chief Executive Officer | 2020 | 960,000 | 0 | — | — | 11,200 | 1,538,200 | 
| Jane H. Hsiao | Chief Technical Officer | 2020 | 900,000 | 0 | — | — | 11,200 | 1,478,200 | 
| Jon R. Cohen | Executive Chairman, Senior Vice President | 2020 | 575,000 | 1,150,000 | — | — | 11,200 | 3,491,200 | 
| Fiscal Year | Employee Count | 
|---|---|
| 2024 | 2,997 | 
| 2023 | 3,930 | 
| 2022 | 4,196 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Revenue | 713,142,000 | 863,495,000 | 1,004,196,000 | 
| Cost Of Revenue | 494,632,000 | 445,830,000 | 627,548,000 | 
| Gross Profit | 218,511,000 | — | — | 
| Research And Development Expenses | 105,214,000 | 89,593,000 | 73,887,000 | 
| General And Administrative Expenses | 304,220,000 | 300,559,000 | 372,672,000 | 
| Operating Expenses | 865,207,000 | 1,020,516,000 | 1,230,449,000 | 
| Operating Income | -152,065,000 | -157,021,000 | -226,253,000 | 
| Net Income | -53,224,000 | -188,863,000 | -328,405,000 | 
| Earnings Per Share Basic | -0.08 | -0.25 | -0.46 | 
| Earnings Per Share Diluted | 0.01 | — | -0.46 | 
| Weighted Average Shares Outstanding Basic | 694,019,535 | 751,765,915 | 719,060,942 | 
| Weighted Average Shares Outstanding Diluted | -5,322,400,000 | — | 719,060,942 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Cash And Cash Equivalents | 426,582,000 | 95,881,000 | 153,191,000 | 
| Marketable Securities Current | — | — | — | 
| Accounts Receivable | 118,017,000 | 123,379,000 | 127,312,000 | 
| Inventories | 56,797,000 | 65,697,000 | 74,060,000 | 
| Non Trade Receivables | — | — | — | 
| Other Assets Current | 10,705,000 | 7,673,000 | 6,252,000 | 
| Total Assets Current | 662,089,000 | 309,476,000 | 394,525,000 | 
| Marketable Securities Non Current | 54,584,000 | 16,082,000 | 28,080,000 | 
| Property Plant And Equipment | 70,134,000 | 75,429,000 | — | 
| Other Assets Non Current | 18,537,000 | 9,080,000 | 8,679,000 | 
| Total Assets Non Current | 1,538,123,000 | 1,702,222,000 | 1,772,734,000 | 
| Total Assets | 2,200,212,000 | 2,011,698,000 | 2,167,259,000 | 
| Accounts Payable | 47,071,000 | 69,677,000 | 66,993,000 | 
| Deferred Revenue | 6,000 | 0 | 0 | 
| Short Term Debt | 14,849,000 | 27,293,000 | 33,540,000 | 
| Other Liabilities Current | 118,357,000 | 90,086,000 | 98,269,000 | 
| Total Liabilities Current | 193,096,000 | 200,052,000 | 213,480,000 | 
| Long Term Debt | 437,203,000 | 249,345,000 | 256,251,000 | 
| Other Liabilities Non Current | 32,838,000 | 27,189,000 | 27,371,000 | 
| Total Liabilities Non Current | 641,668,000 | 422,427,000 | 392,131,000 | 
| Total Liabilities | 834,764,000 | 622,479,000 | 605,611,000 | 
| Common Stock | 7,015,000 | 7,820,000 | 7,813,000 | 
| Retained Earnings | -2,065,010,000 | -2,011,786,000 | -1,822,923,000 | 
| Accumulated Other Comprehensive Income | -56,130,000 | -38,030,000 | -43,323,000 | 
| Total Shareholders Equity | 1,365,448,000 | 1,389,219,000 | 1,561,648,000 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Depreciation And Amortization | 98,176,000 | 105,297,000 | 108,655,000 | 
| Share Based Compensation Expense | 11,048,000 | 11,413,000 | 18,509,000 | 
| Other Non Cash Income Expense | — | — | 0 | 
| Change In Accounts Receivable | 220,000 | -3,411,000 | -128,602,000 | 
| Change In Inventories | -4,217,000 | -15,197,000 | -13,662,000 | 
| Change In Non Trade Receivables | — | — | — | 
| Change In Other Assets | -237,000 | 288,000 | -1,935,000 | 
| Change In Accounts Payable | -20,662,000 | 2,828,000 | -9,388,000 | 
| Change In Other Liabilities | — | -11,559,000 | -90,781,000 | 
| Cash From Operating Activities | -183,489,000 | -28,197,000 | -95,189,000 | 
| Purchases Of Marketable Securities | 0 | 5,000,000 | 0 | 
| Sales Of Marketable Securities | 166,604,000 | 364,000 | 115,423,000 | 
| Acquisition Of Property Plant And Equipment | 25,010,000 | 16,275,000 | 24,578,000 | 
| Acquisition Of Business | 0 | 0 | 1,758,000 | 
| Other Investing Activities | — | — | — | 
| Cash From Investing Activities | 352,214,000 | -18,198,000 | 91,038,000 | 
| Tax Withholding For Share Based Compensation | — | — | — | 
| Payments Of Dividends | — | 0 | 33,000,000 | 
| Issuance Of Common Stock | — | — | — | 
| Repurchase Of Common Stock | 90,223,000 | — | — | 
| Issuance Of Long Term Debt | 250,000,000 | — | — | 
| Repayment Of Long Term Debt | 475,061,000 | 679,709,000 | 1,035,774,000 | 
| Other Financing Activities | — | — | — | 
| Cash From Financing Activities | 184,166,000 | -11,303,000 | 22,971,000 | 
| Change In Cash | 349,734,000 | -57,310,000 | 18,481,000 | 
| Cash At End Of Period | 426,582,000 | 95,881,000 | 153,191,000 | 
| Income Taxes Paid | 10,008,000 | 3,712,000 | 8,037,000 | 
| Interest Paid | 20,883,000 | 8,135,000 | 7,420,000 | 
| Fiscal Year | 2024 | 2023 | 2022 | 
|---|---|---|---|
| Earnings Per Share | -0.08 | -0.25 | -0.46 | 
| Price To Earnings Ratio | -18.375 | -6.04 | -2.7174 | 
| Earnings Growth Rate | -68 | -45.6522 | 820 | 
| Price Earnings To Growth Ratio | 0.2702 | 0.1323 | -0.0033 | 
| Book Value Per Share | 1.9674 | 1.8479 | 2.1718 | 
| Price To Book Ratio | 0.7472 | 0.8171 | 0.5756 | 
| Ebitda | 102,425,000 | -66,348,000 | -199,657,000 | 
| Enterprise Value | 1,045,678,716.45 | 1,315,923,531.65 | 1,035,426,177.5 | 
| Dividend Yield | — | 0 | 0.0367 | 
| Dividend Payout Ratio | — | 0 | -0.1005 | 
| Debt To Equity Ratio | 0.3311 | 0.1991 | 0.1856 | 
| Capital Expenditures | 92,881,000 | — | — | 
| Free Cash Flow | -276,370,000 | — | — | 
| Return On Equity | -0.039 | -0.1359 | -0.2103 | 
| One Year Beta | 1.0431 | 1.4131 | 1.5114 | 
| Three Year Beta | 1.416 | 1.4548 | 1.1722 | 
| Five Year Beta | 1.1791 | 1.2302 | 1.2418 | 
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction | 
|---|---|---|---|---|---|
| FROST PHILLIP MD ET AL | Director, CEO & Chairman, 10% owner | 2025-08-18 | 440,000 | D | 214,236,448 | 
| FROST PHILLIP MD ET AL | Director, CEO & Chairman, 10% owner | 2025-08-08 | 675,000 | A | 214,676,448 | 
| Nabel Gary J. | Director, Chief Innovation Officer | 2025-05-27 | 437,500 | A | 437,500 | 
| Logal Adam | Sr. Vice President, CFO | 2025-05-27 | 437,500 | A | 437,500 | 
| Rubin Steven D | Director, Executive VP-Administration | 2025-05-27 | 437,500 | A | 437,500 | 
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount | 
|---|---|---|---|---|---|---|
| Carlos Curbelo | 2017-10-03 | FL26 | Purchase | 2017-09-26 | — | $1,001 - $15,000 | 
| Carlos Mr Curbelo | 2017-03-02 | FL26 | Purchase | 2017-03-02 | — | $1,001 - $15,000 | 
| Carlos Mr Curbelo | 2017-02-07 | FL26 | Purchase | 2017-02-07 | — | $1,001 - $15,000 | 
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security | 
|---|---|---|---|---|
| TEACHER RETIREMENT SYSTEM OF TEXAS | 2025-09-30 | 126,363 | 81,525 | 1.55 | 
| Parkside Financial Bank & Trust | 2025-09-30 | 613 | 395 | 1.5519 | 
| STRS OHIO | 2025-09-30 | 49,445 | 31,900 | 1.55 | 
| Simplicity Wealth,LLC | 2025-09-30 | 15,500 | 10,000 | 1.55 | 
| Root Financial Partners, LLC | 2025-09-30 | 155 | 100 | 1.55 | 
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets | 
|---|---|---|---|---|---|---|
| SEI INSTITUTIONAL INVESTMENTS TRUST | 2025-08-31 | SIIT Extended Market Index Fund - Class A | SMXAX | 53,584 | 73,945.92 | 0.0061 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Ultra Russell2000 | UWM | 36,614 | 50,527.32 | 0.0138 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Russell 2000 High Income ETF | ITWO | 7,675 | 10,591.5 | 0.0171 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Hedge Replication ETF | HDG | 446 | 615.48 | 0.0026 | 
| PROSHARES TRUST | 2025-08-31 | ProShares Russell 2000 Dynamic Buffer ETF | RB | 508 | 701.04 | 0.0171 |